Systematic review and meta-analysis: SGLT2 inhibitors, blood pressure and cardiovascular outcomes

OBJECTIVE: Clinical trials suggest that SGLT2 inhibitors reduce the risk of cardiovascular mortality in patients with type 2 diabetes, however the mechanism is unclear. Our objective was to test the hypothesis that blood pressure reduction is one potential mechanism underlying the observed improveme...

Descripción completa

Detalles Bibliográficos
Autores principales: Benham, Jamie L., Booth, Jane E., Sigal, Ronald J., Daskalopoulou, Stella S., Leung, Alexander A., Rabi, Doreen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892922/
https://www.ncbi.nlm.nih.gov/pubmed/33659605
http://dx.doi.org/10.1016/j.ijcha.2021.100725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892922/
https://www.ncbi.nlm.nih.gov/pubmed/33659605
http://dx.doi.org/10.1016/j.ijcha.2021.100725

Ejemplares similares